Aisling closes on $650M

Former Perseus-Soros firm will invest in private and public companies with third life sciences fund

1 February 2009•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.